type 1 diabetes and glp 1 GLP-1 Agonists - What is it? GLP-1 receptor agonists and type
Description
This positions GLP-1RAs as promising candidates for averting or postponing the development of vessel plaque accumulation and inflammation in individuals at risk of CVD
Explore nutrition
This effect leads to a feeling of fullness and helps control post-meal spikes in blood sugar levels
Individual timelines vary based on genetics, starting dose, and personal sensitivity
S1 meal type S2 meal type: F 1,4 = 0.35, p = 0.58), as also implied by the Treatment S2 meal type interactions (against Vehicle control: F 1,4 = 6.97, p = 0.058, against Baseline control: F 1,4 = 9.72, p = 0.036)
